# Regadenoson

NDC: 0641-6253
Generic name: Regadenoson
Labeler / Manufacturer: Hikma Pharmaceuticals USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20230403

FDA application: ANDA215827

## Active ingredients

- REGADENOSON ANHYDROUS: .08 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0641-6253"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0641-6253
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9e48b407-1ce3-461d-b48e-de183802de25